Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials. [electronic resource]
Producer: 20040406Description: 2933-47 p. digitalISSN:- 0264-410X
- AIDS Vaccines -- adverse effects
- Adolescent
- Adult
- Canarypox virus -- genetics
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Double-Blind Method
- Female
- HIV-1 -- immunology
- Humans
- Male
- Middle Aged
- National Institutes of Health (U.S.)
- Randomized Controlled Trials as Topic
- Salmonella -- genetics
- Time
- United States
- Vaccines, Subunit -- adverse effects
- Vaccines, Synthetic -- adverse effects
- Vaccinia virus -- genetics
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.